A new urine-based clear cell renal cell carcinoma (ccRCC) recurrence test could reduce the number of CT scans needed to monitor patients with kidney cancer following surgery, as well as providing a “more comfortable alternative to post-operative monitoring.”
Urine Test Could Halve Number Of CT Scans For Patients With Kidney Cancer
Elypta Presented Results For GAGome Test At European Association of Urology Congress
The urine-based GAGome test showed promise in the first clinical results from the international AURORAX-0087A, in the largest study conducted on clear cell renal cell carcinoma, the most common type of kidney cancer.
